{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:26:20Z","timestamp":1791721580033,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03 CA230829"],"award-info":[{"award-number":["R03 CA230829"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03 CA227218"],"award-info":[{"award-number":["R03 CA227218"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03 CA212890"],"award-info":[{"award-number":["R03 CA212890"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.taap.2020.115071","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T19:12:30Z","timestamp":1590261150000},"page":"115071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis"],"prefix":"10.1016","volume":"401","author":[{"given":"Angela Lincy Prem Antony","family":"Samy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velavan","family":"Bakthavachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Vudutha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Vinjamuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaiah","family":"Chinnapaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-6311","authenticated-orcid":false,"given":"Gnanasekar","family":"Munirathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2020.115071_bb0005","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1200\/JCO.2008.20.0642","article-title":"Selective inhibition of CYP17 with Abiraterone acetate is highly active in the treatment of castration-resistant prostate Cancer","volume":"27","author":"Attard","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2020.115071_bb0010","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/mt.2012.155","article-title":"Targeting TCTP as a new therapeutic strategy in castration-resistant prostate Cancer","volume":"20","author":"Baylot","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.taap.2020.115071_bb0015","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/annonc\/mdn288","article-title":"Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa","volume":"19","author":"Berthold","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2020.115071_bb0020","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22152","article-title":"Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1\/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)","volume":"8","author":"Bhattacharyya","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2020.115071_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00647","article-title":"Homeobox a5 promotes white adipose tissue Browning through inhibition of the Tenascin C\/toll-like receptor 4\/nuclear factor kappa B inflammatory Signaling in mice","volume":"9","author":"Cao","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2020.115071_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.taap.2020.115071_bb0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.freeradbiomed.2019.08.025","article-title":"Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H2O2)-mediated oxidative stress","volume":"143","author":"Chinnapaka","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2020.115071_bb0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ctrv.2013.02.002","article-title":"Treat cancers by targeting survivin: just a dream or future reality?","volume":"39","author":"Coumar","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2020.115071_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.toxlet.2015.04.005","article-title":"Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines","volume":"235","author":"Dalzell","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2020.115071_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.fct.2018.02.018","article-title":"Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling","volume":"115","author":"Dasari","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2020.115071_bb0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2018.03.029","article-title":"Polygodial analog induces apoptosis in LNCaP prostate cancer cells","volume":"828","author":"Dasari","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2020.115071_bb0060","first-page":"1","article-title":"Neferine, an alkaloid from lotus seed embryo targets HeLa and SiHa cervical cancer cells via pro-oxidant anticancer mechanism","author":"Dasari","year":"2020","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.taap.2020.115071_bb0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of Artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115071_bb0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.tibs.2015.09.006","article-title":"SUMOylation-mediated regulation of cell cycle progression and Cancer","volume":"40","author":"Eifler","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.taap.2020.115071_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pdpdt.2017.10.026","article-title":"Photodynamic therapy using pheophorbide and 670 nm LEDs exhibits anti-cancer effects in-vitro in androgen dependent prostate cancer","volume":"21","author":"Gheewala","year":"2018","journal-title":"Photodiagnosis and photodynamic therapy"},{"key":"10.1016\/j.taap.2020.115071_bb0080","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1158\/1535-7163.MCT-17-0157","article-title":"Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic \u03b2-catenin Signaling and EMT progression","volume":"16","author":"Hafeez","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2020.115071_bb0085","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.eururo.2012.08.058","article-title":"Cabazitaxel plus prednisone for metastatic castration-resistant prostate Cancer progressing after Docetaxel: results from the German compassionate-use programme","volume":"63","author":"Heidenreich","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.taap.2020.115071_bb0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/annonc\/mdn665","article-title":"Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer","volume":"20","author":"Hussain","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2020.115071_bb0095","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.23014","article-title":"YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2020.115071_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ab.2008.10.005","article-title":"A modified Western blot protocol for enhanced sensitivity in the detection of a membrane protein","volume":"384","author":"Kaur","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2020.115071_bb0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/pros.22574","article-title":"Embelin inhibits growth and induces apoptosis through the suppression of Akt\/mTOR\/S6K1 signaling cascades","volume":"73","author":"Kim","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.taap.2020.115071_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in Cancer therapy: a double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2020.115071_bb0120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/elps.11501601175","article-title":"Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome","volume":"16","author":"Klose","year":"1995","journal-title":"Electrophoresis"},{"key":"10.1016\/j.taap.2020.115071_bb0125","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21147","article-title":"Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer","volume":"8","author":"Kosaka","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2020.115071_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1083\/jcb.66.1.188","article-title":"Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining","volume":"66","author":"Krishan","year":"1975","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.taap.2020.115071_bb0135","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-14-0980-T","article-title":"Selective inhibition of SIN3 Corepressor with Avermectins as a novel therapeutic strategy in triple-negative breast Cancer","volume":"14","author":"Kwon","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2020.115071_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-6148-10-1","article-title":"Detection of clonal antigen receptor gene rearrangement in dogs with lymphoma by real-time polymerase chain reaction and melting curve analysis","volume":"10","author":"Langner","year":"2014","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.taap.2020.115071_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2020.115071_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-017-0560-y","article-title":"PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt\/\u03b2-catenin signaling pathway","volume":"36","author":"Li","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.taap.2020.115071_bb0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.taap.2020.115071_bb0160","series-title":"Hormone-Refractory Prostate Cancer","volume":"16","author":"Lorenzo","year":"2007"},{"key":"10.1016\/j.taap.2020.115071_bb0165","article-title":"Chloroquine and hydroxychloroquine for cancer therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.taap.2020.115071_bb0170","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.15252\/emmm.201404084","article-title":"The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer","volume":"6","author":"Melotti","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.taap.2020.115071_bb0175","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.1158\/0008-5472.CAN-07-1343","article-title":"YM155, a novel small-molecule Survivin suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts","volume":"67","author":"Nakahara","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2020.115071_bb0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11626-010-9303-5","article-title":"Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening","volume":"46","author":"Narwani","year":"2010","journal-title":"Vitro Cell. Dev. Biol. - Anim."},{"key":"10.1016\/j.taap.2020.115071_bb0185","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-10-3978","article-title":"Antihelminth compound Niclosamide Downregulates Wnt Signaling and elicits antitumor responses in Tumors with activating APC mutations","volume":"71","author":"Osada","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2020.115071_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1743-7563.2011.01506.x","article-title":"Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: the Australian perspective: emerging therapies for mCRPC","volume":"8","author":"Parente","year":"2012","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.taap.2020.115071_bb0195","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ajpath.2012.06.040","article-title":"PAGE4 positivity is associated with attenuated AR Signaling and predicts patient survival in hormone-naive prostate Cancer","volume":"181","author":"Sampson","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2020.115071_bb0200","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3368","article-title":"Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy","volume":"6","author":"Santer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2020.115071_bb0205","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/ijc.27936","article-title":"Cell-based selection provides novel molecular probes for cancer stem cells","volume":"132","author":"Sefah","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2020.115071_bb0210","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","article-title":"The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells","volume":"116","author":"Sharmeen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.taap.2020.115071_bb0215","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0020-7519(96)00123-3","article-title":"Eprinomectin: a novel avermectin for use as a topical endectocide for cattle","volume":"26","author":"Shoop","year":"1996","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.taap.2020.115071_bb9052","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2020.115071_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","article-title":"Adding Chloroquine to conventional treatment for Glioblastoma Multiforme: a randomized, double-blind, Placebo-Controlled Trial","volume":"144","author":"Sotelo","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.taap.2020.115071_bb0225","series-title":"Mammalian Cell Viability","first-page":"1","article-title":"Cell viability assays: introduction","volume":"740","author":"Stoddart","year":"2011"},{"issue":"3","key":"10.1016\/j.taap.2020.115071_bb0230","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.bbrc.2018.07.105","article-title":"Nano-chemotherapeutic efficacy of (\u2212)-epigallocatechin 3-gallate mediating apoptosis in A549 cells: involvement of reactive oxygen species mediatedNrf2\/Keap1signaling","volume":"503","author":"Velavan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2020.115071_bb0235","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4161\/cbt.7.12.7067","article-title":"Cancer cell killing via ROS: to increase or decrease, that is the question","volume":"7","author":"Wang","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.taap.2020.115071_bb0240","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.tiv.2011.07.007","article-title":"Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2","volume":"25","author":"Wang","year":"2011","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2020.115071_bb0245","article-title":"Drug screening identifies Niclosamide as an inhibitor of breast Cancer stem-like cells","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2020.115071_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmech.2018.02.045","article-title":"Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors","volume":"149","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2020.115071_bb0255","article-title":"The anthelmintic drug Niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast Cancer model","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2020.115071_bb0260","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.etap.2017.04.013","article-title":"Apoptosis of leukemia K562 and Molt-4 cells induced by emamectin benzoate involving mitochondrial membrane potential loss and intracellular ca 2+ modulation","volume":"52","author":"Yun","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115071_bb0265","first-page":"1681","article-title":"Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells: Genistein enhances Cabazitaxel chemotherapy","volume":"73","author":"Zhang","year":"2013","journal-title":"Prostate"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:46:21Z","timestamp":1777455981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X20301952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":53,"alternative-id":["S0041008X20301952"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115071","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115071"}}